Read + Share
Amedeo Smart
Independent Medical Education
Necchi A, Pouessel D, Leibowitz R, Gupta S, et al. Pemigatinib for metastatic or surgically unresectable urothelial carcinoma with FGF/FGFR genomic alterations: final results from FIGHT-201. Ann Oncol 2024;35:200-210.PMID: 37956738
Email
LinkedIn
Facebook
Twitter
Privacy Policy